Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061395) titled 'Investigation of Urological Cancer Biomarkers by Analyzing Exosome-derived MicroRNA' on April 27.
Study Type:
Observational
Primary Sponsor:
Institute - Keio University
Condition:
Condition - Renal, Urothelial, and Prostate cancers
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To achieve early diagnosis of the three major urological cancers (renal, urothelial, and prostate cancers) by analyzing exosomal microRNAs in body fluids such as blood, urine, and saliva.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 10
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients at our institution who are currently undergoing or are expected to undergo treatment for renal, urothelial, or prostate cancer will be included. In addition, patients with benign conditions, such as urolithiasis and benign prostatic hyperplasia, who visit or are admitted for treatment will be enrolled as controls.
Key exclusion criteria - Patients without informed consent
Target Size - 800
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2019 Year 03 Month 25 Day
Date of IRB - 2019 Year 03 Month 25 Day
Anticipated trial start date - 2019 Year 03 Month 26 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070244
Disclaimer: Curated by HT Syndication.
